
	August 5, 2008

Now Available:
Watch video podcasts of the 2008 EULAR press conferences

CME Opportunity:

Musculoskeletal Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.

Arthritis: Tiny Mitochondria May Have Big Role in OA
Mitochondrial dysfunction appears to play a major role in knee OA, and mitochondrial DNA haplotypes partly determine whether OA will develop and its severity...

Arthritis: Frankincense Extract Safe, Effective in OA
An enriched extract of frankincense reduced pain and improved physical functioning in people with osteoarthritis (OA) in just 7 days...

Consumer News: Proposed Bill Would Finalize Sunscreen Labeling Rules
Two US Senators have introduced a bill designed to compel the FDA to make a set of proposed rules on sunscreen labeling final...

BioPharm Business: Roche Reports US FDA Advisory Committee Recommends Approval of Actemra; if Approved, Would Be First IL-6 Inhibitor for the Treatment of RA
Hoffmann-La Roche announced that the Arthritis Advisory Committee of the US FDA recommended approval of Actemra (tocilizumab), a novel interleukin-6 (IL-6) receptor-inhibiting humanized monoclonal antibody...

BioPharm Business: Manhattan Pharmaceuticals Reports Phase IIa Results of PTH (1-34) for Psoriasis; Cream is Well Tolerated but No Significant Improvement in Treated Lesions Compared With Vehicle
Data from from the phase IIa clinical study of a reformulated topical PTH (1-34) for the treatment of psoriasis did not demonstrate a statistically significant improvement in the overall disease severity of treatment lesions or signs and symptoms of psoriasis compared with vehicle gel...